10d
MLive - GrandRapids/Muskegon/Kalamazoo on MSNKalamazoo researchers have discovered what causes a common kidney diseaseKALAMAZOO, MI -- Scientists at Western Michigan University Homer Stryker School of Medicine (WMed) have made a ...
13d
WWMT Grand Rapids/Lansing on MSNWMed researchers make groundbreaking discovery into cause of common kidney diseaseA research team at Western Michigan University Homer Stryker M.D. School of Medicine has made a significant discovery.
The case was a tricky one, a surgery was inevitable. The patient had lost a lot of blood. He was also in severe pain. Then, ...
A team of researchers at Western Michigan University's Homer Stryker M.D. School of Medicine has made a monumental ...
KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.
—The screening protocol for intracranial aneurysm in patients with autosomal dominant polycystic kidney disease should be based on the presence and size of the aneurysm, family history, and age ...
The complex nephrectomy was followed by a kidney transplant. The patient was discharged three days after the surgery and is ...
Jason Yondura’s cellphone rings, and the caller has a number he doesn’t recognize. Though it’s most likely a spam call, ...
(RTTNews) - Regulus Therapeutics Inc. (RGLS) Wednesday announced positive clinical as well as regulatory updates from its autosomal dominant polycystic kidney disease (ADPKD) program.
Using a handheld dynamometer to assess hip flexion and abduction strength during dialysis was reliable and safe, researchers found in a cross-sectional study.“Subjects in stages 3 and 4 of [chronic ...
Regulus Therapeutics Inc.’s RGLS share price has surged by 23.00%, which has investors questioning if this is right time to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results